4 days ago
RVNC
AnalystsVamil DivanVamil Divan's Stock Forecasts
AnalystsVamil Divan
Analyst Ranking
Top 3%
#126 out of 4241 analysts
Average Return
+14.94%
Win Rate
55%61 out of 111
Risk vs Reward
Poor
Good
Vamil Divan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +702.34% | $1.28 | $10.27 | 2022-05-25 - 2023-05-24 | Strong Buy |
Cabaletta Bio IncCABA | +313.27% | $1.96 | $8.10 | 2022-03-18 - 2023-03-17 | Strong Buy |
Revance Therapeutics IncRVNC | +170.20% | $13.22 | $35.72 | 2022-05-11 - 2023-05-11 | Strong Buy |
Axsome Therapeutics IncAXSM | +98.88% | $35.84 | $71.28 | 2022-05-03 - 2023-05-02 | Strong Buy |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | +98.67% | $70.47 | $140.00 | 2021-05-11 - 2022-05-10 | Strong Buy |
Vamil Divan Analyst Color
Get additional color on Vamil Divan's coverage of popular stocks
a month ago
ANIP
2 months ago
SCYX
3 months ago
JNJ
9 months ago
RVNC
10 months ago
KRTX
a year ago
ABBV
a year ago
PFE
Vamil Divan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Revance Therapeutics IncRVNC | 3 | Strong Buy | $35.00 | +17.17% | Maintains | 4 days ago |
Ani Pharmaceuticals IncANIP | 2 | Strong Buy | $59.00 | +19.22% | Maintains | a month ago |
Chinook Therapeutics IncKDNY | 2 | Strong Buy | $35.00 | +45.89% | Maintains | a month ago |
Travere Therapeutics IncTVTX | 2 | Strong Buy | $23.00 | +37.97% | Maintains | a month ago |
Abbvie IncABBV | 15 | Strong Buy | $171.00 | +23.75% | Maintains | a month ago |
Scynexis IncSCYX | 2 | Strong Buy | $9.00 | +226.09% | Maintains | 2 months ago |
Calliditas Therapeutics AbCALT | 1 | Hold | $18.00 | +5.26% | Initiates Coverage On | 3 months ago |
Aerovate Therapeutics IncAVTE | 1 | Strong Buy | $36.00 | +127.27% | Initiates Coverage On | 3 months ago |
Johnson & JohnsonJNJ | 6 | Hold | $161.00 | +0.62% | Initiates Coverage On | 3 months ago |
Sage Therapeutics IncSAGE | 5 | Hold | $45.00 | -24.42% | Maintains | 4 months ago |
Satsuma Pharmaceuticals IncSTSA | 5 | Hold | $2.00 | +81.82% | Downgrades | 7 months ago |
Acadia Pharmaceuticals IncACAD | 7 | Hold | $19.00 | -23.14% | Maintains | 10 months ago |
Karuna Therapeutics IncKRTX | 6 | Strong Buy | $276.00 | +21.25% | Maintains | 10 months ago |
Neurocrine Biosciences IncNBIX | 5 | Hold | $98.00 | +4.94% | Maintains | 10 months ago |
Alkermes PLCALKS | 7 | Strong Buy | $34.00 | +9.22% | Maintains | 10 months ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $49.00 | N/A | Maintains | a year ago |
Eli Lilly & CoLLY | 12 | Strong Buy | $356.00 | N/A | Maintains | a year ago |
Xeris Biopharma Holdings IncXERS | 1 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 9 | Strong Buy | $154.00 | N/A | Maintains | a year ago |
Pfizer IncPFE | 11 | Hold | $56.00 | N/A | Maintains | a year ago |
Relmada Therapeutics IncRLMD | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Evolus IncEOLS | 4 | Strong Buy | $15.00 | N/A | Upgrades | 2 years ago |
Allergan PLCAGN | 9 | Hold | $155.00 | N/A | Maintains | 4 years ago |
Teva Pharmaceutical Industries LtdTEVA | 10 | Hold | $20.00 | N/A | Maintains | 4 years ago |
Galapagos NvGLPG | 3 | Buy | N/A | N/A | Upgrades | 4 years ago |
Portola Pharmaceuticals IncPTLA | 6 | Hold | $30.00 | N/A | Maintains | 5 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Hold | $17.00 | N/A | Maintains | 5 years ago |
Merck & Co IncMRK | 5 | Buy | $81.00 | N/A | Maintains | 5 years ago |
Corvus Pharmaceuticals IncCRVS | 3 | Buy | $15.00 | N/A | Assumes | 5 years ago |
Aimmune Therapeutics IncAIMT | 3 | Buy | $40.00 | N/A | Maintains | 5 years ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $61.00 | N/A | Maintains | 5 years ago |
Allena Pharmaceuticals IncALNAQ | 2 | Buy | $21.00 | N/A | Maintains | 5 years ago |
Esperion Therapeutics IncESPR | 2 | Buy | $103.00 | N/A | Initiates Coverage On | 5 years ago |
Myokardia IncMYOK | 1 | Buy | $55.00 | N/A | Maintains | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.